Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.
(2015) In JAMA: The Journal of the American Medical Association 313(7). p.707-716- Abstract
- Fondaparinux was associated with reduced major bleeding events and improved survival compared with low-molecular-weight heparin (LMWH) in a large randomized clinical trial involving patients with non-ST-segment elevation myocardial infarction (NSTEMI). Large-scale experience of the use of fondaparinux vs LMWH in a nontrial setting is lacking.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/5143471
- author
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- JAMA: The Journal of the American Medical Association
- volume
- 313
- issue
- 7
- pages
- 707 - 716
- publisher
- American Medical Association
- external identifiers
-
- pmid:25688782
- wos:000349476100016
- scopus:84923170038
- pmid:25688782
- ISSN
- 1538-3598
- DOI
- 10.1001/jama.2015.517
- language
- English
- LU publication?
- yes
- id
- de61832b-00f7-4a82-9fc3-e6a71a320293 (old id 5143471)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25688782?dopt=Abstract
- date added to LUP
- 2016-04-01 10:07:10
- date last changed
- 2022-02-24 22:33:08
@article{de61832b-00f7-4a82-9fc3-e6a71a320293, abstract = {{Fondaparinux was associated with reduced major bleeding events and improved survival compared with low-molecular-weight heparin (LMWH) in a large randomized clinical trial involving patients with non-ST-segment elevation myocardial infarction (NSTEMI). Large-scale experience of the use of fondaparinux vs LMWH in a nontrial setting is lacking.}}, author = {{Szummer, Karolina and Oldgren, Jonas and Lindhagen, Lars and Carrero, Juan Jesus and Evans, Marie and Spaak, Jonas and Edfors, Robert and Jacobson, Stefan H and Andell, Pontus and Wallentin, Lars and Jernberg, Tomas}}, issn = {{1538-3598}}, language = {{eng}}, number = {{7}}, pages = {{707--716}}, publisher = {{American Medical Association}}, series = {{JAMA: The Journal of the American Medical Association}}, title = {{Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.}}, url = {{http://dx.doi.org/10.1001/jama.2015.517}}, doi = {{10.1001/jama.2015.517}}, volume = {{313}}, year = {{2015}}, }